Global Lung Cancer Surgery Market, By Type (Surgical Instruments, Monitoring & Visualizing Systems), Procedure (Robotic Surgery, Thoracotomy, Lobectomy, Sleeve Resection, Endobronchial Surgery, Pneumonectomy, Percutaneous Surgery, Segmentectomy, Minimally Invasive Surgeries), Treatment (Hospitals, Clinics, Ambulatory Surgical Centers, Research Laboratories), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Lung cancer surgery market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 8.50% in the above-mentioned forecast period. Increase in the number of incidences and prevalence of lung cancer all over the globe drives the lung cancer surgery market.
Lung cancer is a type of cancer which starts in the lungs where in the initial tumors develops and a person experiences a problem in breathing. It is the most detected cancer among the global population. Tobacco smoking, exposure to secondhand smoke, radon gas and asbestos are the leading causes of lung cancer. A surgical method or procedure is followed for the removal of tumor. Some people experience pain and complications after the surgery but it usually controlled by the medication. There are generally two types of lung cancer that is small cell lung cancer and non-small cell lung cancer.
Increase in the technological advancement and upgradation in lung cancer treatment is the vital factor escalating the market growth, also rise in the geriatric population, high awareness levels among the general population about cancer treatment, increase in the pollution levels of cigarette smokers all over the globe and rise in the government funding for research & development of new drugs and treatment procedures are the major factors among others driving the lung cancer surgery market. Moreover, rise in the technological advancements and modernization in the healthcare techniques, rise in the research and development activities in the healthcare sector and rise in the emerging markets will further create new opportunities for lung cancer surgery market in the forecasted period of 2021-2028.
However, high cost of lung cancer surgeries is the major factor among others which will obstruct the market growth, and will further challenge the growth of lung cancer surgery market in the forecast period mentioned above.
Lung cancer surgery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lung cancer surgery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Lung Cancer Surgery Market Scope and Market Size
Lung cancer surgery market is segmented on the basis of type, procedure and treatment. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, lung cancer surgery market is segmented into surgical instruments and monitoring & visualizing systems.
- Based on procedure, the lung cancer surgery market is segmented into robotic surgery, thoracotomy, lobectomy, sleeve resection, endobronchial surgery, pneumonectomy, percutaneous surgery, segmentectomy and minimally invasive surgeries.
- The lung cancer surgery market is also segmented on the basis of treatment into hospitals, clinics, ambulatory surgical centers and research laboratories.
Lung Cancer Surgery Market Country Level Analysis
Lung cancer surgery market is analysed and market size insights and trends are provided by country, type, procedure and treatment as referenced above.
The countries covered in the lung cancer surgery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the lung cancer surgery market due to rise in the geriatric population and high awareness levels among the general population about cancer treatment in this region. Asia-Pacific is the expected region in terms of growth in lung cancer surgery market due to rise in the geriatric population and high awareness levels among the general population about cancer treatment in this region.
The country section of the lung cancer surgery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Lung cancer surgery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for lung cancer surgery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the lung cancer surgery market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Lung Cancer Surgery Market Share Analysis
Lung cancer surgery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to lung cancer surgery market.
The major players covered in the lung cancer surgery market report are Accuray Incorporated, Medical Devices Business Services, Inc, Intuitive Surgical, AngioDynamics, Olympus Corporation, KARL STORZ SE & Co. KG, Scanlan International, TROKAMED GmbH, Pfizer Inc., F.Hoffmann-La Roche Ltd., Genentech Inc., Boehringer Ingelheim International GmbH, Abbott, Boston Scientific Corporation, Koninklijke Philips N.V., B. Braun Melsungen AG, Smith & Nephew, Medtronic, Richard Wolf GmbH, BD, Baxter and General Electric among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Lung Cancer Surgery Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.